Overexpression of JMJD3 promoted EMT, proliferation, invasion and migration of epithelial ovarian cancer cells in vitro, and enhanced metastatic capacities in vivo by promoting the growth factor-β (TGF-β1) expression (Liang et al. 2019). The gene discussed is KDM6B; the disease is ovarian carcinoma.